Page last updated: 2024-08-23
phorbol 12,13-dibutyrate and edelfosine
phorbol 12,13-dibutyrate has been researched along with edelfosine in 1 studies
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Bittman, R; Davenport, R; Dryden, P; Howard, S; Jones, K; Salari, H | 1 |
Other Studies
1 other study(ies) available for phorbol 12,13-dibutyrate and edelfosine
Article | Year |
---|---|
Inhibition of protein kinase C by ether-linked lipids is not correlated with their antineoplastic activity on WEHI-3B and R6X-B15 cells.
Topics: Antineoplastic Agents; Cell Compartmentation; Cell Division; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; Phorbol 12,13-Dibutyrate; Phospholipid Ethers; Protein Kinase C; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured | 1992 |